Cipla
Cipla - One of the Leading Global Pharmaceutical Companies in India, Cipla.
Launch date
Employees
Market cap
€16.5b
Enterprise valuation
€15.7b (Public information from Sep 2024)
Share price
INR1618.65002 CIPLA.NS
Mumbai Maharashtra (HQ)
Financials
Estimates*
INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 190.0b | 216.3b | 224.7b | 254.5b | 279.0b | 307.4b | 325.1b |
% growth | 14 % | 14 % | 4 % | 13 % | 10 % | 10 % | 6 % |
EBITDA | 44.4b | 47.1b | 55.0b | 66.9b | 70.2b | 78.1b | 78.3b |
% EBITDA margin | 23 % | 22 % | 24 % | 26 % | 25 % | 25 % | 24 % |
Profit | 24.0b | 25.2b | 28.0b | 41.2b | 47.0b | 52.8b | 53.1b |
% profit margin | 13 % | 12 % | 12 % | 16 % | 17 % | 17 % | 16 % |
EV / revenue | 3.5x | 3.8x | 3.2x | 4.5x | 4.5x | 4.0x | 3.7x |
EV / EBITDA | 14.8x | 17.2x | 13.0x | 17.2x | 18.1x | 15.9x | 15.5x |
R&D budget | 1.3b | 2.7b | 3.9b | 4.3b | - | - | - |
R&D % of revenue | 1 % | 1 % | 2 % | 2 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Cipla
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Cipla
EditACQUISITION by Allergan Nov 2016
ACQUISITION by Cipla Sep 2015
ACQUISITION by Cipla Sep 2015
ACQUISITION by Cipla Jul 2018
ACQUISITION by Cipla Jul 2013
ACQUISITION by Cipla May 2015
ACQUISITION by TruDoc Feb 2024